323 related articles for article (PubMed ID: 33066921)
1. Clinical Trial Based Rationale for the Successful Use of DOAC in the Treatment of Cerebral Venous Sinus Thrombosis (CVST): A Case Report.
Bando T; Ueno Y; Shimo D; Kuroyama T; Mikami K; Hori S; Hirai O
J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105261. PubMed ID: 33066921
[TBL] [Abstract][Full Text] [Related]
2. Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis.
Lurkin A; Derex L; Fambrini A; Bertoletti L; Epinat M; Mismetti P; Dargaud Y
Cerebrovasc Dis; 2019; 48(1-2):32-37. PubMed ID: 31480062
[TBL] [Abstract][Full Text] [Related]
3. Edoxaban: A direct oral anticoagulant.
Poulakos M; Walker JN; Baig U; David T
Am J Health Syst Pharm; 2017 Feb; 74(3):117-129. PubMed ID: 28122753
[TBL] [Abstract][Full Text] [Related]
4. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
Gómez-Outes A; Terleira-Fernández AI; Lecumberri R; Suárez-Gea ML; Vargas-Castrillón E
Thromb Res; 2014 Oct; 134(4):774-82. PubMed ID: 25037495
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Piazza G; Mani V; Goldhaber SZ; Grosso MA; Mercuri M; Lanz HJ; Schussler S; Hsu C; Chinigo A; Ritchie B; Nadar V; Cannon K; Pullman J; Concha M; Schul M; Fayad ZA;
Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Brekelmans MP; Bleker SM; Bauersachs R; Boda Z; Büller HR; Choi Y; Gallus A; Grosso MA; Middeldorp S; Oh D; Raskob G; Schwocho L; Cohen AT
Thromb Haemost; 2016 Jul; 116(1):155-61. PubMed ID: 27010092
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Cerebral Venous Thrombosis Treated with Direct Oral Anticoagulants in a Japanese Man with Hereditary Protein C Deficiency.
Saito K; Ishii K; Furuta K; Kobayashi M; Wada Y; Morishita E
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105320. PubMed ID: 33131982
[TBL] [Abstract][Full Text] [Related]
8. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients.
Einhäupl K; Stam J; Bousser MG; De Bruijn SF; Ferro JM; Martinelli I; Masuhr F;
Eur J Neurol; 2010 Oct; 17(10):1229-35. PubMed ID: 20402748
[TBL] [Abstract][Full Text] [Related]
9. Direct oral anticoagulants in the treatment of cerebral venous sinus thrombosis: a single institution's experience.
Rusin G; Wypasek E; Papuga-Szela E; Żuk J; Undas A
Neurol Neurochir Pol; 2019; 53(5):384-387. PubMed ID: 31454061
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of cerebral venous sinus thrombosis with full-dose IV heparin infusion and its clinical outcomes.
Fernandez A; Nair V; Mckeone A; Ho J
Am J Emerg Med; 2017 Aug; 35(8):1208.e1-1208.e3. PubMed ID: 28434771
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
Morishima Y; Honda Y; Kamisato C; Shibano T
Thromb Res; 2013 Aug; 132(2):234-9. PubMed ID: 23768448
[TBL] [Abstract][Full Text] [Related]
12. Preliminary findings regarding the use of direct oral anticoagulants in cerebral venous thrombosis.
Hsu A; Mistry H; Lala N; Reagan JL
Clin Neurol Neurosurg; 2020 Nov; 198():106204. PubMed ID: 32937276
[TBL] [Abstract][Full Text] [Related]
13. Direct factor Xa inhibitor edoxaban: from bench to clinical practice.
Brekelmans M; Middeldorp S; Coppens M
Expert Rev Hematol; 2015 Dec; 8(6):707-25. PubMed ID: 26560872
[TBL] [Abstract][Full Text] [Related]
14. Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
Raskob GE; van Es N; Segers A; Angchaisuksiri P; Oh D; Boda Z; Lyons RM; Meijer K; Gudz I; Weitz JI; Zhang G; Lanz H; Mercuri MF; Büller HR;
Lancet Haematol; 2016 Aug; 3(8):e379-87. PubMed ID: 27476789
[TBL] [Abstract][Full Text] [Related]
15. Endovascular treatment of cerebral venous sinus thrombosis (CVST): Is a complete recanalization required for a good clinical outcome?
Lozano-Ros A; Luque-Buzo E; García-Pastor A; Castro-Reyes E; Díaz-Otero F; Vázquez-Alen P; Fernández-Bullido Y; Villanueva-Osorio JA; Gil-Núñez A
J Neuroradiol; 2016 Feb; 43(1):51-4. PubMed ID: 26517947
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Direct Oral Anticoagulants and Warfarin in the Treatment of Deep Venous Thrombosis in the Chronic Phase.
Wakakura S; Hara F; Fujino T; Hamai A; Ohara H; Kabuki T; Harada M; Ikeda T
Int Heart J; 2018 Jan; 59(1):126-135. PubMed ID: 29279522
[TBL] [Abstract][Full Text] [Related]
17. [Hokusai-VTE: edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism].
Sprynger M
Rev Med Liege; 2013 Oct; 68(10):548-51. PubMed ID: 24298731
[TBL] [Abstract][Full Text] [Related]
18. Treatment of venous thrombosis with an oral direct factor Xa inhibitor edoxaban by single and multiple administrations in rats.
Morishima Y; Kamisato C; Honda Y
Eur J Pharmacol; 2014 Nov; 742():15-21. PubMed ID: 25179572
[TBL] [Abstract][Full Text] [Related]
19. EFNS guideline on the treatment of cerebral venous and sinus thrombosis.
Einhäupl K; Bousser MG; de Bruijn SF; Ferro JM; Martinelli I; Masuhr F; Stam J
Eur J Neurol; 2006 Jun; 13(6):553-9. PubMed ID: 16796579
[TBL] [Abstract][Full Text] [Related]
20. Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment.
Masuhr F; Mehraein S
Neurocrit Care; 2004; 1(3):355-61. PubMed ID: 16174934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
